Two Californian firms, Gilead Sciences and Arcus Biosciences, have doubled down on their commitment to developing new therapies using the TIGIT pathway. 30 January 2024
UK-based dermatology company SkinBioTherapeutics plc is to acquire the issued share capital of Dermatonics, a specialist in innovative topical and dermatologica 25 January 2024
Washington University in Missouri, USA, has joined forces with the life sciences investment company Deerfield Management to launch a new R&D venture. 17 January 2024
Industry analyst GlobalData has presented research into the growing market for GLP-1 therapies, noting the significance of Roche’s recent acquisition in this ar 12 January 2024
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.